Liang Zhou | Clinical Pharmacology | Best Researcher Award

Published on by Shen Awards

Ms. Liang Zhou | Clinical Pharmacology | Best Researcher Award

Shanghai Henlius Biotech Inc., China

Ms. Liang Zhou is a distinguished clinical pharmacology professional with extensive experience in oncology drug development, pharmacokinetics, and translational research. She earned her Master’s degree in Drug Metabolism and Pharmacokinetics from the China Pharmaceutical University in 2008, which laid the foundation for her successful career in pharmaceutical sciences. Over the years, she has held progressive positions in leading global and Chinese organizations, including Associate Senior Scientist at Wuxi Apptec, Demo Chemist at Thermo Fisher Shanghai, Associate Director of Clinical Pharmacology at Mosim, and currently serves as the Senior Director of Clinical Pharmacology at Shanghai Henlius Biotech, Inc. since 2021. In these roles, she has contributed to more than 11 significant clinical trial programs across China, Australia, Japan, Europe, and the United States, with a strong focus on first-in-human (FIH) trials, PK/PD analysis, and oncology indications such as breast cancer, lymphoma, AML, NSCLC, gastric and pancreatic cancers, among others. Her research interests center on oncology drug development, dose exploration studies, biomarker integration, and regulatory science to accelerate access to novel therapies. With 23 academic documents, 91 citations, and an h-index of 4, Ms. Zhou demonstrates measurable scholarly impact, supported by her memberships in professional societies such as the Chinese Society of Clinical Oncology (CSCO). She has also enhanced her expertise through specialized training in GCP compliance, oncology drug development, and advanced pharmacometrics including R-language applications. Her skills encompass pharmacokinetic modeling, clinical trial design, regulatory submission, and team leadership, which collectively position her as a key figure in clinical pharmacology. Recognized for her contributions to cancer research and drug development, she continues to build a strong professional profile with the potential for international recognition. In conclusion, Ms. Liang Zhou’s blend of academic excellence, clinical research leadership, and commitment to advancing oncology therapeutics makes her a deserving candidate for prestigious awards and a driving force in global biomedical innovation.

Profile: Scopus

Featured Publications

Li, X., Zhang, Y., Wang, J., Chen, H., Zhou, L., Liu, M., … [et al.]. (2023). HLX22, an anti-HER-2 monoclonal antibody, in patients with advanced solid tumors overexpressing human epidermal growth factor receptor 2: An open-label, dose-escalation, phase 1 trial.(5)

CANAN AKÜNAL | Clinical Biochemistry | Best Researcher Award

Published on by Shen Awards

Assoc Prof Dr. CANAN AKÜNAL | Clinical Biochemistry | Best Researcher Award

NEUROLOGY DEPARTMENT LECTURER, ASSOCIATE PROFESSOR at Bolu Abant Izzet Baysal University,Department of Neurology, Faculty of Medicine, Turkey

Dr. Canan Akünal Türel is an Associate Professor in the Department of Neurology at Bolu Abant İzzet Baysal University. She earned her Bachelor’s Degree from Ankara University and completed her specialization at the University of Health Sciences. Her research focuses on neurodegenerative diseases, epilepsy, and the impact of various pharmacological agents on neurological conditions. Dr. Türel has led several national and TÜBİTAK-supported projects investigating the effects of drugs and biomarkers in neurological disorders, including epilepsy and Alzheimer’s disease. She has published extensively in international journals, contributing valuable insights into the electrophysiological and anti-inflammatory effects of different compounds. Her work includes evaluating the role of inflammation and neuroinflammatory biomarkers in various neurological conditions. Additionally, Dr. Türel actively participates in teaching and mentoring students in neurology and related fields. Her dedication to advancing understanding in neurology and her impactful research make her a strong candidate for the Research for Best Researcher Award.

Profile

Education

Dr. Canan Akünal Türel holds an extensive educational background in the field of medicine and neurology. She completed her Bachelor’s Degree at Ankara University, Faculty of Medicine, in June 2005. Following this, she pursued her specialization in Medicine at the University of Health Sciences, Ankara Diskapi Yıldırım Beyazıt Health Research Center, earning her degree on December 28, 2011. Her specialization thesis focused on “Comparing Swallowing Function Disorders in Acute Stroke with Bedside Tests and Electrophysiological Data,” supervised by Bilge Koçer and S. Semih Çomoğlu. Dr. Türel further advanced her expertise through her role as an Associate Professor at Bolu Abant İzzet Baysal University, where she has contributed significantly to the field of neurology. Her academic journey reflects a deep commitment to advancing knowledge in neurology and stroke research.

Professional Experience

Dr. Canan Akünal Türel is an Associate Professor in the Department of Neurology at Bolu Abant İzzet Baysal University, where she has significantly contributed to the field of neurology since August 2018. Her academic journey began with a bachelor’s degree in medicine from Ankara University in 2005, followed by a specialization in medicine at the University of Health Sciences in 2011. She has since supervised numerous theses and engaged in a range of research projects, including studies on epilepsy models and neuroinflammatory biomarkers. Dr. Türel has been involved in national scientific projects and has published extensively in international journals. Her professional roles also include participation in various scientific organizations and teaching courses related to neurological disorders and treatments. Her research interests include epilepsy, neurodegenerative diseases, and the impact of neuroinflammation.

Research Interest

Dr. Canan Akünal Türel is an Associate Professor specializing in neurology with a focus on stroke, epilepsy, and neurodegenerative diseases. Her research explores the electrophysiological and anti-inflammatory effects of various pharmacological agents in experimental models, particularly related to epilepsy and Alzheimer’s disease. Dr. Türel’s work includes investigating the impact of cyclooxygenase inhibition on epileptiform activity, the role of oleanolic acid in seizures, and the effects of novel compounds like esculetin and daidzein on epilepsy. Additionally, her studies delve into the neuroinflammatory biomarkers in acute and chronic neuropathies and the pathophysiological role of infections in neurodegenerative conditions. Dr. Türel also examines the clinical and electrophysiological evaluations in neurological disorders, contributing valuable insights into treatment strategies and disease mechanisms. Her multidisciplinary approach aims to advance the understanding and management of complex neurological conditions through innovative research methodologies.

Research Skills

Dr. Canan Akünal Türel possesses a robust set of research skills underscoring her expertise in neurology and related fields. Her proficiency encompasses both theoretical and practical aspects of medical research. She is adept at conducting complex studies on neurodegenerative diseases, epileptic disorders, and the pharmacological effects of various compounds. Dr. Türel’s research involves advanced techniques such as electrophysiological measurements and inflammatory biomarker analyses. Her work includes supervising doctoral research and managing multiple national and international research projects, reflecting her strong project management and leadership abilities. Dr. Türel has also demonstrated skill in publishing high-impact articles in reputable journals, presenting her findings at scientific conferences, and contributing to academic books. Her comprehensive understanding of neurological diseases and experimental models, combined with her methodological expertise, makes her a significant contributor to her field.

Award and Recognition

Dr. Canan Akünal Türel is an esteemed Associate Professor at Abant İzzet Baysal University, recognized for her significant contributions to neurology and neurophysiology. Her work has been prominently featured in high-impact international journals, including the International Journal of Environmental Health Research and Physiological Reports. Dr. Türel’s research focuses on the electrophysiological and anti-inflammatory effects of various treatments for neurological disorders, such as epilepsy and Alzheimer’s disease. She has received acclaim for her leadership in national scientific projects, notably her roles in investigating the effects of different compounds in experimental epilepsy models and exploring neuroinflammatory biomarkers in neuropathies. Her achievements are further highlighted by her active membership in prestigious scientific organizations and her contributions to national and international conferences. Dr. Türel’s dedication and expertise have established her as a leading figure in her field, making her a deserving candidate for recognition in research excellence.

Conclusion

Dr. Canan Akünal Türel is a strong candidate for the “Best Researcher Award” due to her extensive research experience, significant publication record, and active involvement in academic projects and supervision. Her contributions to neurology, particularly in understanding and treating neurological disorders, are commendable. Addressing areas such as increasing international collaboration and enhancing research visibility could further strengthen her candidacy and impact in the field.

Publications Top Notes

  1. Electrophysiologic and Anti-Inflammatorial Effects of Cyclooxygenase Inhibition in Epileptiform Activity
    • Authors: Akunal Türel, C.; Çelik, H.; Çetinkaya, A.; Türel, İ.
    • Year: 2023
    • Journal: Physiological Reports
    • Volume: 11
    • Issue: 17
    • Article Number: e15800
  2. Oleanolic Acid Suppresses Pentylenetetrazole-Induced Seizure in Vivo
    • Authors: Akünal Türel, C.; Yunusoğlu, O.
    • Year: 2023
    • Journal: International Journal of Environmental Health Research
    • Volume: 33
    • Issue: 5
    • Pages: 529–540
    • Citations: 7
  3. Investigation of the Pharmacological Potential of Myricetin on Alcohol Addiction in Mice
    • Authors: Yunusoğlu, O.; Shahzadi, A.; Akünal Türel, C.; Berköz, M.; Akkan, A.G.
    • Year: 2022
    • Journal: Journal of Research in Pharmacy
    • Volume: 26
    • Issue: 4
    • Pages: 722–733
    • Citations: 3
  4. Evaluation of the Relationship Between Oral Health, Chewing Ability, and Degree of Disease in Alzheimer-Type Dementia Patients
    • Authors: Değirmenci, K.; Akünal Turel, C.
    • Year: 2021
    • Journal: Turk Geriatri Dergisi
    • Volume: 24
    • Issue: 4
    • Pages: 534–545